Notice of Corporate Officer Changes
March 11, 2025, Osaka, Japan – Santen Pharmaceutical Co., Ltd. announced today the appointment of corporate officers effective from April 1, 2025.
List of Corporate Officers effective April 1, 2025
| Name | New Position | Current Position |
|---|---|---|
| Takeshi Ito* | Representative Director of the Board President and Chief Executive Officer | Representative Director of the Board President and Chief Executive Officer |
| Rie Nakajima* | Director of the Board Corporate Officer Chief Operating Officer | Director of the Board Corporate Officer Chief Operating Officer |
| Ippei Kurihara* | Director of the Board Corporate Officer Head of Japan Business, Global Commercial Strategy | Director of the Board Corporate Officer Head of Japan Business, Global Commercial Strategy |
| Marianthi Psaha | Corporate Officer Head of Europe, Middle East and Africa (EMEA) Business | Corporate Officer Head of Europe, Middle East and Africa (EMEA) Business |
| Shawn Xiang | Corporate Officer Head of China Business | Corporate Officer Head of China Business |
| Shinichi Teramachi | Corporate Officer Head of Japan Sales and Marketing Division, Head of Sales Department | Corporate Officer Head of Japan Sales and Marketing Division, Head of Sales Department |
| Tomoyuki Yoshida | Corporate Officer Head of Asia Business | Corporate Officer Head of Asia Business |
| Yoshinori Watanabe | Corporate Officer Head of Sales and Marketing Division – OTC products | Corporate Officer Head of Sales and Marketing Division – OTC products |
| Reza Haque* | Corporate Officer Head of Ophthalmology Innovation Center | Corporate Officer Head of Ophthalmology Innovation Center |
| Peter Sallstig* | Corporate Officer Chief Medical Officer | Corporate Officer Chief Medical Officer |
| Fumiyasu Ako* | Corporate Officer Chief of Staff to CEO | Corporate Officer Chief of Staff to CEO |
| Kazuo Koshiji* | Corporate Officer Chief Financial Officer | Corporate Officer Chief Financial Officer |
| Mika Masunari* | Corporate Officer General Counsel & Chief Compliance Officer | Corporate Officer General Counsel & Chief Compliance Officer |
| Takahiro Morita | Corporate Officer Global Head of Core Principle & Sustainability | Corporate Officer Global Head of Core Principle & Sustainability |
| Daisuke Nakata* (Newly appointed) | Corporate Officer Chief Digital & Information Officer | Global Head of Digital &Information Technology |
| Yoko Saiki* | Corporate Officer Global Head of Corporate Strategy | Corporate Officer Global Head of Corporate Strategy |
* Corporate Management Member (CMM)
About Santen
As a specialized company dedicated to eye health, Santen aspires to contribute to the realization of “Happiness with Vision” by providing products and services to patients, consumers, and medical professionals around the world. Since its establishment, and guided by its CORE PRINCIPLE, “Tenki ni sanyo suru,” Santen has been committed to helping people maintain and improve their eye health for more than 130 years. Santen is engaged in the global research and development, manufacturing, and sales and marketing of pharmaceutical products in the field of eye care, supporting the eye health of approximately 50 million people in more than 60 countries and regions worldwide. Santen’s mission is to provide essential and significant value to patients and society in the prevention, diagnosis, and treatment of eye diseases through products and services created from its expertise in the ophthalmology field and from the patient's perspective. To create a future in which as many patients as possible can lead happy and fulfilling lives, Santen is committed to doing its utmost to realize a society in which people around the world can experience “Happiness with Vision.”
For more information, please visit Santen’s website https://www.santen.com/en.
Contact
Corporate Communications
Santen Pharmaceutical Co., Ltd.
E-mail: communication@santen.com
Official SNS
